Keywords: تومور لنفوسیتها نفوذ می کند; Mitoxantrone; Vaccination; Immunogenic cell death; Colon cancer; Liver metastases; T cells; Immunotherapy; Tumor-infiltrating lymphocytes;
مقالات ISI تومور لنفوسیتها نفوذ می کند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تومور لنفوسیتها نفوذ می کند; TINs; tumor-infiltrating neutrophils; TILs; tumor-infiltrating lymphocytes; NLR; neutrophil/lymphocyte rate; BC; bladder cancer; IHC; immunohistochemistry; OS; overall survival; NMIBC; non-muscle invasive bladder cancer; MIBC; muscle invasive bladder canc
Keywords: تومور لنفوسیتها نفوذ می کند; Immuno-oncology; Checkpoints; Tumor-infiltrating lymphocytes; Macrophages; Natural killer;
Keywords: تومور لنفوسیتها نفوذ می کند; Adoptive cell therapy; Tumor-infiltrating lymphocytes; Malignant pleural effusion and ascites; 4-1BBL, IL-7, IL-15;
Keywords: تومور لنفوسیتها نفوذ می کند; EGFR-TKI; NSCLC; PD-L1; Smoking; Tumor-infiltrating lymphocytes;
Keywords: تومور لنفوسیتها نفوذ می کند; Breast cancer; Triple-negative; Basal-like carcinoma; Tumor-infiltrating lymphocytes; Immunohistochemistry;
Keywords: تومور لنفوسیتها نفوذ می کند; IDC; invasive ductal carcinoma; IL-35; interleukin-35; Tregs; regulatory T cells; TILs; tumor-infiltrating lymphocytes; EBI3; Epstein-Barr Virus (EBV)-induced gene 3; Bregs; regulatory B cells; PFS; progression-free survival; OS; overall survival; ER; est
Keywords: تومور لنفوسیتها نفوذ می کند; CIK; cytokine-induced killer cells; PA-MSHA; Pseudomonas aeruginosa-mannose sensitive hemagglutinin; TILs; tumor-infiltrating lymphocytes; NK; natural killer cell; PD-L1; programmed death receptor ligand 1; DCs; dendritic cells; PRs; partial remissions; S
Keywords: تومور لنفوسیتها نفوذ می کند; Nanotechnology; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Tumor microenvironment;
Keywords: تومور لنفوسیتها نفوذ می کند; Tumor-infiltrating lymphocytes; Breast cancer; Subtypes; Prognosis;
Keywords: تومور لنفوسیتها نفوذ می کند; Immune checkpoint inhibitors; Interleukin-2; Lymphodepletion; Nonmyeloablative chemotherapy; Tumor-infiltrating lymphocytes;
Keywords: تومور لنفوسیتها نفوذ می کند; Tumor-infiltrating lymphocytes; TIL; Breast carcinoma; Adjuvant therapy; Non-neoadjuvant therapy; Overall survival; Disease-free survival;
Keywords: تومور لنفوسیتها نفوذ می کند; Biomarkers; Checkpoint molecules; Cytokines; Glioblastoma; Immunotherapy; Microbiome; Mutational landscape; CB; Cintredekin besudotox; CNS; Central nervous system; CTLA-4; Cytotoxic T lymphocyte antigen 4; CyTOF; Cytometry by time-of-flight; EGFR; Epiderm
Keywords: تومور لنفوسیتها نفوذ می کند; Programmed cell death 1 ligand 1; Tumor-infiltrating lymphocytes; Immune checkpoint; Prognosis; Gastric carcinoma;
Keywords: تومور لنفوسیتها نفوذ می کند; Chemotherapy; TNBCtype; Neoadjuvant; PIK3CA; Androgen receptor; TNBC; triple negative breast cancer; pCR; pathological complete response; HR; homologous recombination; EMT; epithelial-mesenchymal-transition; AR; androgen receptor; TILs; tumor-infiltrati
Keywords: تومور لنفوسیتها نفوذ می کند; Inflammation; Ionizing radiation; Immune biomarkers; Tumor-infiltrating lymphocytes; Tumor-associated macrophages; Low-dose radiation therapy;
Keywords: تومور لنفوسیتها نفوذ می کند; Melanoma; Tumor-infiltrating lymphocytes; Adoptive cell transfer; Lymphodepletion; Interleukin-2ACT, adoptive cell transfer; APC, antigen presenting cell; CI, confidence interval; CR, complete remission; C/T, cancer/testis; CTLA-4, cytotoxic t-lymphocyte-
Keywords: تومور لنفوسیتها نفوذ می کند; checkpoint blockade; immune contexture; immunogenic cell death; natural killer cells; tumor-associated macrophages; tumor-infiltrating lymphocytes
Keywords: تومور لنفوسیتها نفوذ می کند; metastatic melanoma; rapid expansion; tumor-infiltrating lymphocytes; Wave bioreactor;
Keywords: تومور لنفوسیتها نفوذ می کند; Phage antibody library; Cell-based selection; BSA; bovine serum albumin; CEA; carcino embryonic antigen; ELISA; enzyme-linked immunosorbent assay; FACS; fluorescence-activated cell sorting; HRP; horseradish peroxidase; PBS; phosphate-buffered saline; PEG;
Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy
Keywords: تومور لنفوسیتها نفوذ می کند; CTLA4; Cytotoxic T lymphocyte-associated antigen 4; DCs; Dendritic cells; IL-12; Interleukine-12; MDSCs; Myeloid-derived suppressor cells; NK cells; Natural killer cells; PAPs; Proapoptotic peptides; PD1; Programmed cell death protein 1; Tregs; Regulatory
Percutaneous ablative cryoimmunotherapy for micrometastaic abscopal effect: No complications
Keywords: تومور لنفوسیتها نفوذ می کند; Abscopal effect; Cancer stem cell; Checkpoint inhibitor; Cryoimmunotherapy; Neoantigen; Renal cell carcinoma; Tumor microenvironment; Tumor vaccine; PD-1; programmed death 1; TIL; tumor-infiltrating lymphocytes; ECM; extracellular matrix; TAA; tumor-assoc
Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1
Keywords: تومور لنفوسیتها نفوذ می کند; Oropharyngeal cancer; Human papillomavirus; PD-1; Tim-3; Tumor-infiltrating lymphocytes;
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer
Keywords: تومور لنفوسیتها نفوذ می کند; Ovarian cancer; Overall survival; Inflammation; Neutrophil-to-lymphocyte ratio; Lactate Dehydrogenase; Tumor-infiltrating lymphocytes;
Notch signaling pathway dampens tumor-infiltrating CD8+ T cells activity in patients with colorectal carcinoma
Keywords: تومور لنفوسیتها نفوذ می کند; CCK-8; cell counting kit-8; CTLA-4; cytotoxic T-lymphocyte associated protein-4; DAPT; N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenyl glycinet-butyl ester; FBS; fetal bovine serum; GM-CSF; granulocyte-macrophage colony stimulating factor; IFN-γ; interf
The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Keywords: تومور لنفوسیتها نفوذ می کند; Head and neck cancer; Squamous cell carcinoma; Programmed death-ligand 1; PD-L1; HPV; Tumor-infiltrating lymphocytes; TIL; Survival; Meta-analysis;
Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
Keywords: تومور لنفوسیتها نفوذ می کند; Osteoglycin; Tumor-infiltrating lymphocytes; Colorectal cancer; Immune response; Survival;
PD-1 pathway and its clinical application: A 20Â year journey after discovery of the complete human PD-1 gene
Keywords: تومور لنفوسیتها نفوذ می کند; hPD-1; Human Programmed Cell Death 1; PD-L; program death ligand; TILs; tumor-infiltrating lymphocytes; mAb; monoclonal antibody; NSCLC; non-small-cell lung cancer; RCC; renal-cell carcinoma; UBC; urothelial bladder cancer; TTF; time-to-treatment failure;
Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins
Keywords: تومور لنفوسیتها نفوذ می کند; Immune checkpoint proteins (ICPs); miRNAs; Cancer immune escape; Antigen-MHC; antigen-major histocompatibility complex; ICPs; immune checkpoint proteins; 3â²UTR; 3â² untransltated region; PD-1; programmed cell death protein; Tregs; regulatory T cells; H
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Bre
Keywords: تومور لنفوسیتها نفوذ می کند; Tumor-infiltrating lymphocytes; Breast cancer; Neoadjuvant; Residual disease; Ductal carcinoma in situ; Residual cancer burden;
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy
Keywords: تومور لنفوسیتها نفوذ می کند; Tumor-infiltrating lymphocytes; Non-small cell lung cancer; Immune checkpoint inhibitor; Regulatory T cells; Tumor microenvironment;
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
Keywords: تومور لنفوسیتها نفوذ می کند; AICD; activation-induced cell death; AML; acute myeloid leukemia; APC; antigen-presenting cells; CAR; coxsackie- and adenovirus receptor; CDKs; cyclin-dependent kinases; CG; cancer germline; DCs; dendritic cells; HAT; histone acetyltransferase; HDAC; hist
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Keywords: تومور لنفوسیتها نفوذ می کند; TILs; Tumor-infiltrating lymphocytes; NSCLC; Prognosis; Lung cancer; Immunoscore;
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer
Keywords: تومور لنفوسیتها نفوذ می کند; Cancer vaccine; Cytotoxic T cells; Melanoma; Breast cancer; Tumor-infiltrating lymphocytes;
FOXOs in cancer immunity: Knowns and unknowns
Keywords: تومور لنفوسیتها نفوذ می کند; 2B4; CD244 molecule; AKT or PKB; protein kinase B; APCs; antigen-presenting cells; ARG1; arginase 1; BEC; blood endothelial cell; BLNK; B cell Linker protein; BMP; bone morphogenetic protein; BTK; Bruton tyrosine kinase; C/EBP; CCAAT/enhancer-binding prot
Combined modality neoadjuvant treatment for stage III/IV melanoma with PD-1 blockade plus radiation: A case series
Keywords: تومور لنفوسیتها نفوذ می کند; Neoadjuvant; PD-1 Inhibitors; Hypofractionated radiation therapy; Melanoma; Tumor-infiltrating lymphocytes; Molecular pathology;
Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer
Keywords: تومور لنفوسیتها نفوذ می کند; High grade serous ovarian cancer; PD-L1; Tumor-infiltrating lymphocytes; Prognosis;
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: AÂ RENAPE study
Keywords: تومور لنفوسیتها نفوذ می کند; Peritoneal mesothelioma; Epithelioid subtype; PD-L1; Immunohistochemistry; Survival; EPMM; epithelioid peritoneal malignant mesothelioma; PD-L1; programmed death-ligand 1; PD-1; programmed death 1; CRSÂ +Â HIPEC; cytoreductive surgery combined with hypert
A high ratio of IL-12Rβ2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer
Keywords: تومور لنفوسیتها نفوذ می کند; Tumor-infiltrating lymphocytes; Tumor microenvironment; Laryngeal squamous cell carcinoma; Interleukin-12 receptor β2; Prognosis;
Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers
Keywords: تومور لنفوسیتها نفوذ می کند; ACT; adoptive cellular immunotherapy; AICD; activation induced cell death; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; BsAb; bispecific antibody; CA125; cancer antigen-125; CARs; chimeric antigen receptors; CBMCs; cord blood mononuclear
Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma
Keywords: تومور لنفوسیتها نفوذ می کند; Canine; Urothelial carcinoma; Urinary bladder; Tumor-infiltrating lymphocytes; Anti-tumor immunity;
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer
Keywords: تومور لنفوسیتها نفوذ می کند; Breast cancer; Triple negative; Tumor-infiltrating lymphocytes; CD4; CD8;
Development of novel avenues to overcome challenges facing CAR T cells
Keywords: تومور لنفوسیتها نفوذ می کند; AICD; activation-induced cell death; AMP; adenosine monophosphate; APC; antigen-presenting cells; ATP; adenosine triphosphate; CAFs; cancer-associated fibroblasts; CAR; chimeric antigen receptor; CEA; carcinoembryonic antigen; CTLA4; cytotoxic T-lymphocyt
The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma
Keywords: تومور لنفوسیتها نفوذ می کند; Mesothelioma; Immunohistochemistry; PD-L1; Tumor-infiltrating lymphocytes; Copy number aberrations;
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma
Keywords: تومور لنفوسیتها نفوذ می کند; Multiplex fluorescent labeling; Cancer immunology; Breast cancer; Immunohistochemistry; Tumor-infiltrating lymphocytes;
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Keywords: تومور لنفوسیتها نفوذ می کند; Tumor-infiltrating lymphocytes; Neoadjuvant treatment; HER2-postive breast cancer; Pathologic complete response; Trastuzumab; Lapatinib;
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Keywords: تومور لنفوسیتها نفوذ می کند; Immunotherapy; GPC3; MAGEC2; Galectin 9; APC; antigen-presenting cells; BTLA; BÂ and T lymphocyte attenuator; CFSE; carboxyfluorescein diacetate succinimidyl ester; CTL; cytotoxic T cells; CTLA4; cytotoxic T-lymphocyte associated protein 4; GAL-9; galecti
Development of CAR T cells designed to improve antitumor efficacy and safety
Keywords: تومور لنفوسیتها نفوذ می کند; 28z; CD28 + CD3ζ; 4-1BBL; 4-1BB ligand; B-ALL; B cell acute lymphatic leukemia; BBz; 4-1BB + CD3ζ; CAR; chimeric antigen receptor; CD40L; CD40 ligand; CRS; cytokine release syndrome; CTLA-4; cytotoxic T-lymphocyte associated protein 4; DCs; dendriti
A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma
Keywords: تومور لنفوسیتها نفوذ می کند; Merkel cell carcinoma; Cutaneous neuroendocrine carcinoma; Tumor-infiltrating lymphocytes; TILS; Tumor-specific CD8Â + T cells; PD-1/PD-L1 pathway; Antitumoral immunity;
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
Keywords: تومور لنفوسیتها نفوذ می کند; TAB; tumor-associated B cells; CD20; Prognosis; Melanoma; Tumor microenvironment; Tumor-associated B cells (TAB); Tumor-infiltrating lymphocytes;